Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Electrical Implant Could Help Incontinence Sufferers Control Their Bladder

By HospiMedica International staff writers
Posted on 28 Apr 2009
A continuous shock to the nerves that control the bladder could help people with urinary incontinence that have run out of other options, according to a new review of studies.

Researchers the from the Dunedin School of Medicine (New Zealand), and Christchurch Hospital (New Zealand) reviewed eight published studies involving 500 patients who underwent sacral neuromodulation with implanted devices, and who had not responded to other less invasive treatments. More...
The reviewers clarified that since it was uncertain whether some reports included patients who also appeared in other reports, no data were pooled from the different studies. The reviewers also said that most of the longer-term studies had a poor follow-up rate, which meant that there were questions about their reliability. Additionally, many of the implants did not work, and many required revision operations.

Overall, the results of the studies showed benefits primarily for patients with symptoms of overactive bladder and with no known obstruction, who had failed other methods of treatment. However, the reviewers stressed that up to 30% of those who are evaluated for the implant are not good candidates and do not receive an implant. Of those who get the implants, another 30% might not see any benefit or find that the implants lose usefulness over time. According to the authors, those who would benefit from the procedure fall into two groups: patients in whom all nonsurgical approaches have been tried and whose symptoms remain bothersome and persistent, and those who are unable to empty their bladder, yet have no discernable mechanical obstruction. The review was published in the April 15, 2009, issue of The Cochrane Library.

"For those who have tried all nonsurgical approaches - including bladder retraining, physiotherapy for the pelvic floor muscles and medications - yet the symptoms persist, it is worth discussing this option with your primary care doctor, who may refer you on to a urologist," said review coauthor Edwin Arnold, M.D., of the department of urology at Christchurch Hospital. "This treatment is not for everyone and even if the operation is undertaken, it does not always work, so a patient's expectations should remain realistic."

Sacral neuromodulation involves a continuous electrical nerve stimulation of the sacral nerve roots, using two implanted electrodes near the sacrum (tailbone), and an implanted pulse generator that generated a continuous shock to the nerves that control the bladder, causing the person to feel an uninterrupted tapping sensation in the pelvic area. However, many questions remain about patient selection and the best way to use these devices.

Related Links:
Dunedin School of Medicine
Christchurch Hospital



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.